Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Barathan Muttiah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Malaysia, the Centre for Research and Instrumentation Management (CRIM), Universiti Kebangsaan Malaysia.
Abstract (Originalsprache)
Helicobacter pylori (H. pylori) infection is a leading cause of gastritis, peptic ulcers, and gastric cancer, affecting more than half of the global population. Its persistence in the acidic gastric environment and its ability to evade host immunity present major treatment challenges. Although antibiotics remain the standard therapy, rising antimicrobial resistance has reduced treatment efficacy, prompting the search for alternative and adjunct approaches. Emerging therapies include probiotics, antimicrobial peptides (AMPs), and plant-derived compounds, which target H. pylori through membrane disruption, immunomodulation, or direct antimicrobial activity. Novel drug delivery systems and microbiota-sparing interventions are also being investigated. Additionally, vaccine development offers a promising strategy for long-term protection, though challenges related to antigenic variability and host-specific responses remain. Despite these advances, treatment variability and the limited clinical validation of alternatives hinder progress. A multifaceted approach integrating microbiome research, host–pathogen interactions, and new therapeutic agents is essential for future success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
- Department of Medical Parasitology and Entomology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi 43600, Malaysia.
- GUT Research Group, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
ORCID-Profile: Barathan Muttiah, Wathiqah Wahid, Asif Sukri
Förderung
- National University of Malaysia
- the Centre for Research and Instrumentation Management (CRIM), Universiti Kebangsaan Malaysia
Zitieren
APA
Muttiah, B., Wahid, W., Sukri, A., & Hanafiah, A. (2025). Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136064
Vancouver
Muttiah B, Wahid W, Sukri A, Hanafiah A. Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136064
BibTeX
@article{Muttiah2025,
author = {Muttiah, Barathan and Wahid, Wathiqah and Sukri, Asif and Hanafiah, Alfizah},
title = {Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136064}
}
EUVIMED